Jeff Yass’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-55,391
Closed -$325K 13865
2023
Q4
$325K Buy
55,391
+45,724
+473% +$541K ﹤0.01% 9663
2023
Q3
$245K Buy
9,667
+299
+3% +$24.6K ﹤0.01% 9786
2023
Q2
$1.3M Buy
9,368
+1,670
+22% +$214K ﹤0.01% 6081
2023
Q1
$701K Sell
7,698
-5,578
-42% -$757K ﹤0.01% 7723
2022
Q4
$1.82M Sell
13,276
-106
-0.8% -$35.9K ﹤0.01% 4890
2022
Q3
$11.6M Buy
13,382
+8,235
+160% +$5.16M ﹤0.01% 1974
2022
Q2
$2.25M Sell
5,147
-4,583
-47% -$2.39M ﹤0.01% 4663
2022
Q1
$6.18M Buy
9,730
+6,398
+192% +$4.03M ﹤0.01% 3291
2021
Q4
$2.97M Buy
+3,332
New +$3.5M ﹤0.01% 4662
2021
Q3
Sell
-913
Closed -$1.11M 13821
2021
Q2
$1.1M Buy
+913
New +$1.23M ﹤0.01% 7494

Other funds holding CANO

Jeff Yass's CANO Position: Q1 2024 in Review

Jeff Yass sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 55,391 shares — an estimated $325K sold.

Jeff Yass first reported a position in CANO in Q2 2021 and held it in 10 quarters. The position peaked at $11.6M in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Jeff Yass reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Jeff Yass sold 55,391 Cano Health, Inc. shares in Q1 2024, an estimated $325K.
  • Jeff Yass first reported a position in Cano Health, Inc. in Q2 2021 and held it in 10 quarters.
  • Jeff Yass's Cano Health, Inc. position peaked at $11.6M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.